[
    [
        {
            "time": "",
            "original_text": "疫苗被喊停阿斯利康以试验数据“自证清白”国内合作方康泰生物着手开展临床试验 经营问题",
            "features": {
                "keywords": [
                    "疫苗",
                    "阿斯利康",
                    "试验数据",
                    "康泰生物",
                    "临床试验",
                    "经营问题"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗被喊停阿斯利康以试验数据“自证清白”国内合作方康泰生物着手开展临床试验 经营问题",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：即将在国内开展阿斯利康新冠疫苗的临床试验",
            "features": {
                "keywords": [
                    "康泰生物",
                    "阿斯利康",
                    "新冠疫苗",
                    "临床试验"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：即将在国内开展阿斯利康新冠疫苗的临床试验",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]